NB-1

Manufacturers: Bone Biologics Corporation

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

Polymerization catalyst
US 7163990 B2Applicant: BP CHEM INT LTDPriority: 2001
US
4 publications
Organic electroluminescent element
US 8604466 B2Applicant: ENDO JUNPriority: 2009
US
WO
3 publications
Modulation of Fas and FasL expression
- US 7662792 B2
  Applicant: BIONICHE LIFE SCIENCES INCPriority: 2001
  US
  3 publications
- WO 0218593 A3
  Applicant: BIONICHE LIFE SCIENCES INCPriority: 2000
  WO
Compounds for inhibition of HIV infection by blocking HIV entry
US 7241803 B2Applicant: NEW YORK BLOOD CT INCPriority: 2003
US
3 publications
Therapeutically useful synthetic oligonucleotides
US 2001041681 A1Applicant: PHILLIPS NIGEL CPriority: 1999
CN
US
2 publications
O/W type emulsion
US 11395798 B2Applicant: NOF CORPPriority: 2015
CN
US
2 publications
Multitarget drug for treating diseases in mammals
US 11584709 B2Applicant: “PHARMENTERPRISES EURASIA” LLCPriority: 2017
CN
US
2 publications
Gene ANSB knockout mutant of citrobacter werkmanii and application thereof
US 11555193 B1Applicant: INST OF MICROBIOLOGY GUANGDONG ACADEMY OF SCIENCES GUANGDONG DETECTION CENTER OF MICROBIOLOGYPriority: 2021
CN
US
2 publications
Blood processing systems and methods using apparent hematocrit as a process of control parameter
US 2001006810 A1Applicant: BAXTER INTPriority: 2001
US
2 publications
Imidazolidinedione derivatives and use thereof as drugs
US 6919365 B2Applicant: SENJU PHARMA COPriority: 2001
US
2 publications